AGP Executive Report
Last update: 16 minutes agoShort Bowel Syndrome Treatment: The EMA’s CHMP has issued a positive opinion for Zealand Pharma’s Zeydovio™ (glepaglutide), recommending marketing authorization for adults with short bowel syndrome—reported as the first major European advance in over a decade, with many patients reducing weekly parenteral support and some weaning off entirely after 24 weeks. Liechtenstein Abortion Politics: Liechtenstein’s Catholic hereditary prince Alois says he will defend unborn life and intends to oppose the abortion bill after Parliament voted 13–12 for a 12-week time-limit regime, setting up a constitutional showdown over whether the prince sanctions the law. Cross-Border Health & Care Tech: A Unified Patent Court injunction blocks MGI Tech from selling or supplying Oxford Nanopore’s CycloneSEQ sequencing systems across several European markets, including Liechtenstein, after claims of patent infringement. Health Policy Context: A week of debate around abortion in Catholic microstates continues, with Liechtenstein’s vote contrasted against Andorra’s plan to decriminalize abortion ahead of elections. Human Rights Watch: The UK and 37 OSCE states have called for the release of all political prisoners in Belarus, citing ongoing repression and politically motivated prosecutions.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
